Three Philadelphia scientists won a $3 million Breakthrough Prize for developing the first FDA-approved gene therapy for a genetic disease, prize sponsors announced Saturday. Their work created a ...
Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...
Molecular biologist Jean Bennett and ophthalmologist Albert Maguire will share the $3 million (£2.2m) "Breakthrough prize" ...
Three life-science prizes were awarded for advances in gene therapies. Opthalmologists Jean Bennett and Albert Maguire, and ...
The Breakthrough Prize Foundation awarded researchers involved in developing gene therapies for blindness and sickle cell ...
The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Scientists discover salamander genes that help regrow limbs, using gene therapy to restore digit growth in mice.
Investigating a common gene in three very different species—salamanders, mice and zebrafish—scientists have discovered the ...
Ultragenyx (NASDAQ:RARE) is one of the 10 Overlooked Growth Stocks to Buy Now.
The treatment for primary immunodeficient diseases is varied. As mentioned before, the most common type of primary immunodeficient disease are antibody deficiencies. Either patients don't make enough ...
Morning Overview on MSN
First human trial tests gene therapy aimed at reversing cellular aging
For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results